Table 4 Influence of baseline BMI on overall symptom change from baseline to end of treatment in the IOT group
|  | Low weight group (N = 18) | High weight group (N = 17) | Z | P [< .05] |
|---|---|---|---|---|
BMI difference | 1.25 (0.46, 1.98) | 1.14 (0.21, 2.29) |  − 0.099 | 0.921 |
Restraint difference |  − 0.70 (− 1.65, 0.00) |  − 0.60 (− 3.20, − 0.30) |  − 1.293 | 0.196 |
Eating concern difference |  − 0.50 (− 1.60, − 0.20) |  − 0.40 (− 2.30, − 0.20) |  − 0.050 | 0.960 |
Shape concern difference |  − 0.50 (− 1.05, 0.20) |  − 0.60 (− 1.80, − 0.30) |  − 1.177 | 0.239 |
Weight concern difference |  − 0.81 (− 1.94, − 0.06) |  − 0.75 (− 2.75, − 0.13) |  − 0.628 | 0.530 |
EDE-Q 6.0 global difference |  − 0.74 (− 1.31, − 0.17) |  − 0.69 (− 2.17, − 0.26) |  − 0.908 | 0.364 |
BDI difference |  − 7.50 (− 14.50, − 3.50) |  − 5.00 (− 9.00, 0.50) |  − 1.984 | 0.050 |
BAI difference |  − 2.00 (− 4.50, − 0.50) |  − 2.00 (− 7.50, 0.50) |  − 0.166 | 0.868 |